SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the International Association of Physicians in AIDS Care (JIAPAC)
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1545109709335751v1
8/3/193    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by James, C. W.
Right arrow Articles by Szabo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, C. W.
Right arrow Articles by Szabo, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Prevalence of Antiretroviral Drug Resistance in Antiretroviral-Naive Individuals

Christopher W. James, PharmD

HIV Community Program, Christiana Care Health System, Wilmington, Delaware

Lee E. Moffett, PharmD

HIV Community Program, Christiana Care Health System, Wilmington, Delaware

Susan Szabo, MD

HIV Community Program, Christiana Care Health System, Wilmington, Delaware, sszabo{at}christianacare.org

Transmitted antiretroviral drug resistance has been an ongoing consideration even in patients who are treatment naive. The authors retrospectively selected all eligible patients from a US-based urban HIV clinic who had a genotypic resistance assay performed prior to the initiation of antiretroviral therapy. Clinically significant resistance was detected in 8% of assays, and was comparable when stratified by duration of time from diagnosis to genotypic resistance assay.

Key Words: HIV • antiretroviral-naive • genotypic • resistance testing

This version was published on May 1, 2009

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 8, No. 3, 193-195 (2009)
DOI: 10.1177/1545109709335751
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement